1Work group on schizophrenia.Practice guidline for the treatment of patients with schizophrenia,Second Edition[J].Am J Psychiatry,2004,161(Suppl 2):1-40.
2Tune LE,Salzman C.Schizophrenia in late life[J].Psychiat Clin North Am,2003,26:104-113.
3Keshavan MS,Kennedy JS.Drug-induce dysfunction in psychiatry[M].New York:Hemisphere Publishing Corporation,1992.93-101.
4Kumar V,Brecher M.Psychopharmacology of atypical antipsychotics and clinical outcomes in elderly patients[J].J Clin Psychiatry,1999,60(Suppl 13):5-9.
5Wirshing WC.Movement disorders associated with neuroleptic treatment[J].J Clin Psychiatry,2001,62(Suppl 21):15-18.
6Alexopoulos GS,Streim J,Carpenter D,et al.The expert consensus guidelines series using antipsychotic agents in older patients[J].J Clin Psychiatry,2004,65(Suppl 2):11-26.
7Moller H,Nasrallah HA.Treatment of bipolar disorder[J].J Clin Psychiatry,2003,64(Suppl 6):6-17.
8Laloude P.Evaluating antipsychotic medications:predictors of clinical effectiveness[J].Can J Psychiatry,2003,48(Suppl 3):4-12.
9Vieweg WR.Mechanisms and risk of electrocardiographic QT interval prolongation when using antipsychotic drug[J].J Clin Psychiatry,2002,63(Suppl 9):18-24.
10Taylor DM.Antipsychotics and QT prolongation[J].Acta Psychiatr Scand,2003,107:85-95.
